Skip to Content

Alvesco Approval History

  • FDA approved: Yes (First approved January 10th, 2008)
  • Brand name: Alvesco
  • Generic name: ciclesonide
  • Dosage form: Inhalation Aerosol
  • Company: Nycomed
  • Treatment for: Asthma

Alvesco (ciclesonide) is an inhaled corticosteroid indicated for the maintenance treatment of asthma and as prophylactic therapy in adult and adolescent patients aged 12 years and older.

Development History and FDA Approval Process for Alvesco

Jan 16, 2008Approval Alvesco Gains FDA Approval for the U.S. Market
Oct 26, 2004Aventis Receives Approvable Letter from U.S. Food and Drug Administration for Alvesco (ciclesonide) for Treatment of Persistent Asthma
Jan  1, 2004Aventis Submits New Drug Application to FDA for Asthma Drug Alvesco (ciclesonide)

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.